2023 annual financial data
Eledon Pharmaceuticals 2023 Net income growth
Direct answer
Net income growth was 54.16%.
Operating income was -43,000,000 USD and net income was -40,326,000 USD.
Operating cash flow was -39,527,000 USD.
Get free Eledon Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -43,000,000 USD
- Net income
- -40,326,000 USD
- Operating cash flow
- -39,527,000 USD